Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CLPT - ClearPoint Neuro, Inc.

IEX Last Trade
15.72
4.065   25.859%

Share volume: 0
Last Updated: Tue 24 Dec 2024 06:18:36 PM CET
Surgical and Medical Instrument Manufacturing : 50.37%

PREVIOUS CLOSE
CHG
CHG%
$11.66
4.07
34.88%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
28%
Profitability 25%
Dept financing 25%
Liquidity 57%
Performance 25%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
1.03%
1 Month
34.58%
3 Months
39.35%
6 Months
180.95%
1 Year
139.41%
2 Year
103.96%
Key data
Stock price
$15.72
P/E Ratio 
0.00
DAY RANGE
$11.66 - $14.78
EPS 
$0.00
52 WEEK RANGE
$5.40 - $17.47
52 WEEK CHANGE
$126.30
MARKET CAP 
358.192 M
YIELD 
N/A
SHARES OUTSTANDING 
27.596 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
2.22
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$184,175
AVERAGE 30 VOLUME 
$232,316
Company detail
CEO: Joseph M. Burnett
Region: US
Website: clearpointneuro.com
Employees: 110
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

ClearPoint Neuro, Inc. develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. ClearPoint system for insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain.

Recent news